The North American sleep apnea devices market is estimated to grow at a CAGR of 15.9% from 2014 to 2019. In 2013, the U.S. held the largest share in the North American sleep apnea devices market with 92.2%, followed by Canada. This market holds high growth potential in the future due to a number of forces favoring this market. These include the continuously growing base of sleep apnea patients, increasing awareness of sleep apnea and available diagnostic/therapeutic options, emerging popularity of oral appliances, and technological advancement. About 4% of men and 2% of women suffer from obstructive sleep apnea (OSA), globally. Due to rising obesity rates, the association of comorbidities such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, the global sleep apnea patient pool is likely to grow in the years to come. However, dearth of reimbursement/insurance coverage and patient compliance seem to be hindering the growth of this market.
In this report, the North American sleep apnea devices market is broadly classified into sleep apnea diagnostic devices and sleep apnea therapeutic devices. On the basis of products, the sleep apnea diagnostic devices market is further divided into home sleep testing/portable monitoring, traditional diagnostic (fixed PSG/in-lab PSG devices), respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Sleep apnea therapeutic devices include positive airway pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances.
Geographically, the market is divided into two countries, namely the U.S. and Canada. The U.S. commanded the largest share of the North American sleep apnea market with 92.2% in 2013, followed by Canada. Canada is estimated to grow at a CAGR of 16.8% during the forecast period from 2014 to 2019. As per the Centers for Disease Control and Prevention (CDC), 36.0% of adults in the U.S. were obese in 2010, and nearly 42% will be obese by 2030. This dramatic increase in the obesity epidemic is likely to add to the pool of sleep apnea patients. According to the American Academy of Sleep Medicine, the number of accredited sleep labs that test for sleep disorders has quadrupled in the past decade. Over-prescription of overnight tests to diagnose apnea has also contributed significantly in escalating the growth of the U.S. sleep apnea diagnostic devices market.
Complete report is available @ .

Leave a Reply

Your email address will not be published. Required fields are marked *